Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to provide evidence that a therapy of Ulcerative Colitis (UC) disease adjusted on tight monitoring of non-invasive parameters, such as clinical symptoms and faecal calprotectin (FC) (substance that is released when intestines are inflamed and that can be measured in faeces), can provide significantly higher benefit for the participants in terms of disease control and quality of life (QoL) improvement, compared to a symptom-based approach only.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04340895
Study type Interventional
Source Ferring Pharmaceuticals
Contact
Status Completed
Phase N/A
Start date October 14, 2019
Completion date October 20, 2023